1. Zagouri, F., Dimopoulos, M. A., Bournakis, E., et al. (2010). Molecular markers in ovarian cancer: Their role in prognosis and therapy. European Journal of Gynaecological Oncology, 31(3), 268–277.
2. Ghezzi, F., Cromi, A., Siesto, G., et al. (2009). Laparoscopy staging of early ovarian cancer: Our experience and review of the literature. International Journal of Gynecological Cancer, 19(Suppl 2), S7–S13.
3. Dinh, P., Harnett, P., Piccart-Gebhart, M. J., et al. (2008). New therapies for ovarian cancer: Cytotoxics and molecularly targeted agents. Critical Reviews in Oncology Hematology, 67(2), 103–112.
4. Connolly, D. C., & Hensley, H. H. (2009). Xenograft and transgenic mice models of epithelial ovarian cancer and non invasive imaging modalities to monitor ovarian tumor growth in situ—applications in evaluating novel therapeutic agents. Current Protocols is Pharmacology, 45(14), 1211–1226.
5. Hai-ying, C., Jing-mao, W., Hong-ying, W., et al. (2012). Effect of short hairpin RNA-induced CXCR4 silence on ovarian cancer cell. Biomedicine & Pharmacotherapy, 66, 549–553.